Literature DB >> 1731701

Ethacrynic acid increases facility of outflow in the human eye in vitro.

L L Liang1, D L Epstein, A W de Kater, A Shahsafaei, K A Erickson-Lamy.   

Abstract

Anterior segments of human donor eyes were perfused with culture medium at a perfusion pressure of 15 mm Hg in a 5% carbon dioxide environment at 37 degrees C. After determination of a baseline facility of outflow, the perfusion chamber contents were exchanged with either drug vehicle or ethacrynic acid, at concentrations ranging from 0.01 to 0.25 mmol/L, after which postdrug facility was measured in the continuous presence of drug vehicle or ethacrynic acid. Ethacrynic acid increased facility of outflow from 28% to 105% at ethacrynic acid concentrations of 0.01 to 0.25 mmol/L, respectively. No morphologic correlate of the facility increase was observed with 0.01-mmol/L ethacrynic acid, nor were there any signs of cellular toxic effects. At 0.1 mmol/L, separations between trabecular meshwork cells and breaks between inner-wall cells were observed. At 0.25 mmol/L, focal areas of cell swelling and necrosis were noted. This study demonstrated that ethacrynic acid increases outflow facility in the aged human eye at concentrations that produce no apparent toxic effects. Therefore, ethacrynic acid may potentially prove useful in the treatment of glaucoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731701     DOI: 10.1001/archopht.1992.01080130108036

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  Outflow tract ablation using a conditionally cytotoxic feline immunodeficiency viral vector.

Authors:  Ze Zhang; Amardeep S Dhaliwal; Harry Tseng; James D Kim; Joel S Schuman; Robert N Weinreb; Nils A Loewen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

Review 2.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

Review 3.  Pharmacological advances in the treatment of glaucoma.

Authors:  J B Serle
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

4.  Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits.

Authors:  John J Arnold; Yash Choksi; Xin Chen; Atsushi Shimazaki; John Hatten; Eric J Toone; David L Epstein; Pratap Challa
Journal:  J Ocul Pharmacol Ther       Date:  2009-06       Impact factor: 2.671

Review 5.  Aqueous outflow: segmental and distal flow.

Authors:  Swarup S Swaminathan; Dong-Jin Oh; Min Hyung Kang; Douglas J Rhee
Journal:  J Cataract Refract Surg       Date:  2014-08       Impact factor: 3.351

Review 6.  The role of the actomyosin system in regulating trabecular fluid outflow.

Authors:  Baohe Tian; B'Ann T Gabelt; Benjamin Geiger; Paul L Kaufman
Journal:  Exp Eye Res       Date:  2008-08-27       Impact factor: 3.467

7.  Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye.

Authors:  Cheng-Wen Lin; Pedro Gonzalez; Fan Yuan
Journal:  Mol Vis       Date:  2011-09-27       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.